诱导多能干细胞疗法报告称是安全的。 - Suppr

Suppr

超能文献

iPS cell therapy reported safe.

作者信息

Normile Dennis

出版信息

Science. 2017 Mar 17;355(6330):1109-1110. doi: 10.1126/science.355.6330.1109.

DOI:10.1126/science.355.6330.1109

PMID:28302802

Abstract

摘要

相似文献

iPS cell therapy reported safe.

Science. 2017 Mar 17;355(6330):1109-1110. doi: 10.1126/science.355.6330.1109.

[Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].

Rinsho Shinkeigaku. 2013;53(11):1013-5. doi: 10.5692/clinicalneurol.53.1013.

[Retinal cell therapy using iPS cells].

Rinsho Shinkeigaku. 2013;53(11):1016. doi: 10.5692/clinicalneurol.53.1016.

[Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].

Yakugaku Zasshi. 2017;137(1):23-29. doi: 10.1248/yakushi.16-00225.

Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?

J Control Release. 2014 Jul 10;185:37-44. doi: 10.1016/j.jconrel.2014.04.011. Epub 2014 Apr 16.

[Regenerative therapy for post-stroke patients].

Nihon Rinsho. 2016 Apr;74(4):661-5.

Good practice.

Nature. 2014 Jun 12;510(7504):187-8. doi: 10.1038/510187b.

[Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].

Brain Nerve. 2012 Jan;64(1):39-46.

[Regenerative medicine for age - related macular degeneration using IPS cells].

Nihon Rinsho. 2015 Jun;73 Suppl 5:442-6.

Induced pluripotent stem cells: an emerging theranostics platform.

Clin Pharmacol Ther. 2011 May;89(5):648-50. doi: 10.1038/clpt.2010.304.

引用本文的文献

Advancing cell-based therapy in sepsis: An anesthesia outlook.

Chin Med J (Engl). 2024 Jul 5;137(13):1522-1534. doi: 10.1097/CM9.0000000000003097. Epub 2024 May 6.

Exposing intracellular molecular changes during the differentiation of human-induced pluripotent stem cells into erythropoietin-producing cells using Raman spectroscopy and imaging.

Sci Rep. 2022 Nov 28;12(1):20454. doi: 10.1038/s41598-022-24725-1.

Strategies for Peripheral Nerve Repair.

Curr Tissue Microenviron Rep. 2020;1(2):49-59. doi: 10.1007/s43152-020-00002-z. Epub 2020 Apr 21.

Pulmonary gene delivery-Realities and possibilities.

Exp Biol Med (Maywood). 2021 Feb;246(3):260-274. doi: 10.1177/1535370220965985. Epub 2020 Nov 12.

Effect of mechanical vibration stress in cell culture on human induced pluripotent stem cells.

Regen Ther. 2019 Jun 6;12:27-35. doi: 10.1016/j.reth.2019.05.002. eCollection 2019 Dec 15.

Proteomics in the World of Induced Pluripotent Stem Cells.

Cells. 2019 Jul 11;8(7):703. doi: 10.3390/cells8070703.

Various nuclear reprogramming systems using egg and oocyte materials.

J Reprod Dev. 2019 Jun 14;65(3):203-208. doi: 10.1262/jrd.2019-002. Epub 2019 Feb 9.

Measles vector as a multigene delivery platform facilitating iPSC reprogramming.

Gene Ther. 2019 May;26(5):151-164. doi: 10.1038/s41434-019-0058-7. Epub 2019 Feb 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

iPS cell therapy reported safe.

Science. 2017 Mar 17;355(6330):1109-1110. doi: 10.1126/science.355.6330.1109.

[Current status and perspective on regenerative medicine for spinal cord injury using iPS cell].

Rinsho Shinkeigaku. 2013;53(11):1013-5. doi: 10.5692/clinicalneurol.53.1013.

[Retinal cell therapy using iPS cells].

Rinsho Shinkeigaku. 2013;53(11):1016. doi: 10.5692/clinicalneurol.53.1016.

[Development of Cellular and Tissue-based Products for Retinal Regenerative Medicine].

Yakugaku Zasshi. 2017;137(1):23-29. doi: 10.1248/yakushi.16-00225.

Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?

J Control Release. 2014 Jul 10;185:37-44. doi: 10.1016/j.jconrel.2014.04.011. Epub 2014 Apr 16.

[Regenerative therapy for post-stroke patients].

Nihon Rinsho. 2016 Apr;74(4):661-5.

Good practice.

Nature. 2014 Jun 12;510(7504):187-8. doi: 10.1038/510187b.

[Induced pluripotent stem (iPS) cell-based cell therapy for muscular dystrophy: current progress and future prospects].

Brain Nerve. 2012 Jan;64(1):39-46.

[Regenerative medicine for age - related macular degeneration using IPS cells].

Nihon Rinsho. 2015 Jun;73 Suppl 5:442-6.

Induced pluripotent stem cells: an emerging theranostics platform.

Clin Pharmacol Ther. 2011 May;89(5):648-50. doi: 10.1038/clpt.2010.304.

引用本文的文献

Advancing cell-based therapy in sepsis: An anesthesia outlook.

Chin Med J (Engl). 2024 Jul 5;137(13):1522-1534. doi: 10.1097/CM9.0000000000003097. Epub 2024 May 6.

Exposing intracellular molecular changes during the differentiation of human-induced pluripotent stem cells into erythropoietin-producing cells using Raman spectroscopy and imaging.

Sci Rep. 2022 Nov 28;12(1):20454. doi: 10.1038/s41598-022-24725-1.

Strategies for Peripheral Nerve Repair.

Curr Tissue Microenviron Rep. 2020;1(2):49-59. doi: 10.1007/s43152-020-00002-z. Epub 2020 Apr 21.

Pulmonary gene delivery-Realities and possibilities.

Exp Biol Med (Maywood). 2021 Feb;246(3):260-274. doi: 10.1177/1535370220965985. Epub 2020 Nov 12.

Effect of mechanical vibration stress in cell culture on human induced pluripotent stem cells.

Regen Ther. 2019 Jun 6;12:27-35. doi: 10.1016/j.reth.2019.05.002. eCollection 2019 Dec 15.

Proteomics in the World of Induced Pluripotent Stem Cells.

Cells. 2019 Jul 11;8(7):703. doi: 10.3390/cells8070703.

Various nuclear reprogramming systems using egg and oocyte materials.

J Reprod Dev. 2019 Jun 14;65(3):203-208. doi: 10.1262/jrd.2019-002. Epub 2019 Feb 9.

Measles vector as a multigene delivery platform facilitating iPSC reprogramming.

Gene Ther. 2019 May;26(5):151-164. doi: 10.1038/s41434-019-0058-7. Epub 2019 Feb 4.